[1]Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis[J]. Endocrinol Metab Clin North Am, 2012, 41(3): 595-611.
[2]Diez-Perez A, Hooven FH, Adachi JD, et al. Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW) [J]. Bone, 2011, 49(3): 493-498.
[3]Sun WX, Zheng HY, Lan J. Edaravone protects osteoblastic cells from dexamethasone through inhibiting oxidative stress and mPTP opening[J]. Mol Cell Biochem, 2015, 409(1-2): 51-58.
[4]Yang M, Huang Y, Chen J, et al. Activation of AMPK participates hydrogen sulfide-induced cyto-protective effect against dexamethasone in osteoblastic MC3T3-E1 cells[J]. Biochem Biophys Res Commun, 2014, 454(1): 42-47.
[5]Murtaza G, Karim S, Akram MR, et al. Caffeic acid phenethyl ester and therapeutic potentials[J]. Biomed Res Int, 2014. DOI: 10.1155/2014/145342.
[6]Kim H, Kim W, Yum S, et al. Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation[J]. Free Radic Biol Med, 2013, 65:552-562.
[7]Lee S, Yoon CY, Byun SS, et al. The role of c-FLIP in cisplatin resistance of human bladder cancer cells[J]. J Urol, 2013, 189(6): 2327-2334.
[8]Liu L, Gu L, Ma Q, et al. Resveratrol attenuates hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells[J]. Eur Rev Med Pharmacol Sci, 2013, 17(1): 88-94.
[9]Liu Y, Zhang SP, Cai YQ. Cytoprotective effects of selenium on cadmium-induced LLC-PK1 cells apoptosis by activating JNK pathway[J]. Toxicol In Vitro, 2007, 21(4): 677-684.
[10]Hseu YC, Chou CW, Senthil Kumar KJ, et al. Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes[J]. Food Chem Toxicol, 2012, 50(5): 1245-1255.
[11]Zhang S, Li D, Yang JY, et al. Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway[J]. Cell Stress Chaperones, 2015, 20(4): 621-629.
[12]Maricic M. Update on glucocorticoid-induced osteoporosis[J]. Rheum Dis Clin North Am, 2011, 37(3): 415-431.
[13]赵建宁, 包倪荣, 王与荣, 等. 地塞米松诱导原代培养的成骨样细胞凋亡的分子细胞学研究[J]. 医学研究生学报, 2004, 17(1): 15-17.
[14]Zhang N, Zhong J, Han S, et al. MicroRNA-378 Alleviates Cerebral Ischemic Injury by Negatively Regulating Apoptosis Executioner Caspase-3[J]. Int J Mol Sci, 2016, 17(9). DOI: 10.3390/ijms17091427.
[15]Krivoruchko A, Storey KB. Forever young: mechanisms of natural anoxia tolerance and potential links to longevity[J]. Oxid Med Cell Longev, 2010, 3(3): 186-198.
[16]Suh KS, Rhee SY, Jung WW, et al. Chrysanthemum zawadskii extract protects osteoblastic cells from highly reducing sugar-induced oxidative damage[J]. Int J Mol Med, 2013, 32(1): 241-250.
[17]Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling[J]. Cell Signal, 2012, 24(5): 981-990.
[18]段家翔, 甯交琳, 鲁开智. Nrf2出核转运机制及意义的研究进展[J]. 医学研究生学报, 2014, 27(8): 874-877.
[19]王笑亮, 王汉东. Nrf2在中枢神经系统疾病中的神经保护作用[J]. 医学研究生学报, 2011, 24(7): 754-757.
[20]Zhang M, An C, Gao Y, et al. Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection[J]. Prog Neurobiol, 2013, 100(1):30-47.
[1]奚 昊,侯 健,袁振刚,等.VTD方案治疗复发难治性多发性骨髓瘤36例[J].医学研究与战创伤救治(原医学研究生学报),2010,12(01):36.
XI Hao,HOU Jian,YUAN Zhen-gang,et al.Efficacy of VTD regimen on 36 patients with relapsed and refractory multiple myeloma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(02):36.
[2]洪铁艳,余正平.来那度胺联合地塞米松方案对复发难治多发性骨髓瘤的治疗作用并文献复习[J].医学研究与战创伤救治(原医学研究生学报),2014,16(06):597.[doi:10.3969/j.issn.1672-271X.2014.06.011]
HONG Tie-yan,YU Zheng-ping..The efficacy and safety of treatment of relapsed and refractory multiple myeloma combining lenalidomide with dexamethasone[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(02):597.[doi:10.3969/j.issn.1672-271X.2014.06.011]
[3]熊文娟,余小骊,欧阳晓春,等.早期地塞米松联合高压氧治疗一氧化碳中毒疗效的头颅MRI观察[J].医学研究与战创伤救治(原医学研究生学报),2015,17(02):191.[doi:10.3969/j.issn.1672-271X.2015.02.025]
[4]张严高,余磊,王建莉,等.地塞米松预处理减轻异丙肾上腺素所致心肌损伤及TNF-α的表达[J].医学研究与战创伤救治(原医学研究生学报),2015,17(05):467.[doi:10.3969/j.issn.1672-271X.2015.05.006]
ZHANG Yan-Gao,YU Lei,WANG Jian-li,et al.Dexamethasone pretreatment reduces isoproterenol-induced myocardial injury and the expression of TNF-α[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(02):467.[doi:10.3969/j.issn.1672-271X.2015.05.006]
[5]段靖,周燕萍,杨辉,等.不同粒径地塞米松纳米混悬剂的体外透皮行为比较研究[J].医学研究与战创伤救治(原医学研究生学报),2019,21(3):273.[doi:10.3969/j.issn.1672-271X.2019.03.011]
DUAN Jing,ZHOU Yan-ping,YANG Hui,et al.Comparative study on in vitro transdermal behavior of dexamethasone nanosuspensions with different particle sizes[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2019,21(02):273.[doi:10.3969/j.issn.1672-271X.2019.03.011]
[6]笪虎,张建萍.局部使用地塞米松预防跟骨同种异体骨植骨术后排异反应的研究[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):411.[doi:10.3969/j.issn.1672-271X.2020.04.017]
[7]高炟鹏,郭宪,余志阳,等.术前单次地塞米松对炎症性肠病术后疼痛和恶心呕吐的影响[J].医学研究与战创伤救治(原医学研究生学报),2021,23(6):570.[doi:10.3969/j.issn.1672-271X.2021.06.003]
GAO Da-peng,GUO Xian,YU Zhi-Yang,et al.Effects of single dexamethasone on postoperative pain, nausea and vomiting in patients with inflammatory bowel disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(02):570.[doi:10.3969/j.issn.1672-271X.2021.06.003]